Orthopediatrics (KIDS) Restructuring Costs (2024 - 2025)

Orthopediatrics (KIDS) recorded quarterly Restructuring Costs of $296000.0 in Q4 2025, down 87.1% quarter-over-quarter from $2.3 million in Q3 2025, and down 91.9% on a YoY basis from $3.7 million in Q4 2024.

Orthopediatrics (KIDS) Restructuring Costs (2024 - 2025) Analysis & Trends

Orthopediatrics' Restructuring Costs history runs 2 years deep, the most recent figure standing at $296000.0 for Q4 2025.

  • In Q4 2025, Restructuring Costs fell 91.9% year-over-year to $296000.0; the TTM figure through Dec 2025 stood at $6.2 million (changed N/A YoY), while the FY2025 annual figure was $5.6 million, up 53.33% from the prior year.
  • Restructuring Costs was $296000.0 for Q4 2025 at Orthopediatrics, down from $2.3 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $3.7 million in Q4 2024 to a low of $296000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Orthopediatrics 424.91 Mn 376.10 Mn 43.39 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 296,000.00
Sep 30, 2025 2.29 Mn
Dec 31, 2024 3.65 Mn